Showing 1 post by James (Jim) A. Dietz.
Kentucky providers with prescriptive authority take note: beginning June 29, 2017, new laws (HB 333) go into effect that significantly impact the prescribing of Schedule II drugs. Schedule II drugs include brand names such as Demerol, OxyContin and Percocet. Read More ›
Ask the Blogger
Do you have a topic that you would like discussed in a future blog article? Please let us know. If you have a confidential question regarding a blog article, please feel free to contact the article's author directly, or let us know if you would like for someone to contact you directly.
Thomas D. Anthony is Chair of FBT's Health Care Industry Practice. He focuses on counseling health care entities on corporate transactions, regulatory compliance and joint ventures.